Found: 32
Select item for more details and to access through your institution.
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00472-2
- By:
- Publication type:
- Article
Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00353-0
- By:
- Publication type:
- Article
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1757, doi. 10.1093/cid/ciae173
- By:
- Publication type:
- Article
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 5, p. 1498, doi. 10.1093/infdis/jiad441
- By:
- Publication type:
- Article
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060944
- By:
- Publication type:
- Article
The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza Vaccination.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 663, doi. 10.3390/vaccines8040663
- By:
- Publication type:
- Article
Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 348, doi. 10.3390/vaccines8030348
- By:
- Publication type:
- Article
Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 69, doi. 10.3390/vaccines8010069
- By:
- Publication type:
- Article
Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 4, doi. 10.3390/vaccines8010004
- By:
- Publication type:
- Article
Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 126, doi. 10.3390/vaccines8010126
- By:
- Publication type:
- Article
Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection.
- Published in:
- PLoS ONE, 2021, v. 16, n. 8, p. 1, doi. 10.1371/journal.pone.0256482
- By:
- Publication type:
- Article
Innate, T-, and B-Cell Responses in Acute Human Zika Patients.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 1, p. 1, doi. 10.1093/cid/cix732
- By:
- Publication type:
- Article
Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 3, p. 376, doi. 10.1093/cid/ciw256
- By:
- Publication type:
- Article
Enhancing SIV-specific immunity in vivo by PD-1 blockade.
- Published in:
- 2009
- By:
- Publication type:
- Letter
2739. Comparison of Hemagglutination Antibody Inhibition (HAI) Titers Following Influenza Vaccination by Birth Cohort and Repeated Influenza Vaccination History.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S964, doi. 10.1093/ofid/ofz360.2417
- By:
- Publication type:
- Article
Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 1, p. N.PAG, doi. 10.1093/ofid/ofy352
- By:
- Publication type:
- Article
Biphasic Zika Illness With Rash and Joint Pain.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 3, p. 1, doi. 10.1093/ofid/ofx133
- By:
- Publication type:
- Article
Pericarditis Associated With Acute Zika Virus Infection in a Returning Traveler.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 2, p. 1, doi. 10.1093/ofid/ofx103
- By:
- Publication type:
- Article
Emergency Postexposure Vaccination With Vesicular Stomatitis Virus-Vectored Ebola Vaccine After Needlestick.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 313, n. 12, p. 1249, doi. 10.1001/jama.2015.1995
- By:
- Publication type:
- Article
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23942-y
- By:
- Publication type:
- Article
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00779-8
- By:
- Publication type:
- Article
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans.
- Published in:
- Science Immunology, 2024, v. 9, n. 94, p. 1, doi. 10.1126/sciimmunol.adi8039
- By:
- Publication type:
- Article
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates.
- Published in:
- Science Immunology, 2023, v. 8, n. 88, p. 1, doi. 10.1126/sciimmunol.adg7015
- By:
- Publication type:
- Article
A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection.
- Published in:
- Science Immunology, 2022, v. 7, n. 72, p. 1, doi. 10.1126/sciimmunol.abo0226
- By:
- Publication type:
- Article
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 5, p. 610
- By:
- Publication type:
- Article
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. Suppl 2, p. 610
- By:
- Publication type:
- Article
Pre-Existing Dengue Immunity Drives a DENV-Biased Plasmablast Response in ZIKV-Infected Patient.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 1, p. 19, doi. 10.3390/v11010019
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of Adjuvants on the Immunogenicity and Efficacy of Split-Virion H7N9 Vaccine in Ferrets.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 4, p. 542, doi. 10.1093/infdis/jiv099
- By:
- Publication type:
- Article
Prevention of Infection by a Granulocyte-Macrophage Colony-Stimulating Factor Co-Expressing DNA/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 1, p. 164, doi. 10.1093/infdis/jir199
- By:
- Publication type:
- Article